Sigma Planning Corp Astrazeneca PLC Transaction History

Sigma Planning Corp

  • $3.32 Billion
  • Q3 2025

A detailed history of Sigma Planning Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Sigma Planning Corp holds 4,603 shares of AZN stock, worth $411,508. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,603
Previous 4,600 0.07%
Holding current value
$411,508
Previous $321,000 9.97%
% of portfolio
0.01%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
BUY
$68.72 - $82.11 $206 - $246
3 Added 0.07%
4,603 $353,000
Q2 2025

Aug 05, 2025
BUY
$64.87 - $75.0 $4,605 - $5,325
71 Added 1.57%
4,600 $321,000
Q1 2025

May 01, 2025
BUY
$65.37 - $77.96 $27,259 - $32,509
417 Added 10.14%
4,529 $332,000
Q4 2024

Feb 03, 2025
SELL
$63.2 - $79.58 $32,232 - $40,585
-510 Reduced 11.03%
4,112 $269,000
Q3 2024

Nov 01, 2024
SELL
$76.67 - $87.62 $63,252 - $72,286
-825 Reduced 15.15%
4,622 $360,000
Q2 2024

Aug 05, 2024
SELL
$66.81 - $80.83 $139,699 - $169,015
-2,091 Reduced 27.74%
5,447 $424,000
Q1 2024

May 01, 2024
BUY
$61.03 - $69.57 $142,688 - $162,654
2,338 Added 44.96%
7,538 $510,000
Q4 2023

Feb 01, 2024
SELL
$61.89 - $69.28 $893,815 - $1 Million
-14,442 Reduced 73.53%
5,200 $350,000
Q3 2023

Nov 06, 2023
SELL
$64.85 - $71.7 $46,238 - $51,122
-713 Reduced 3.5%
19,642 $1.33 Million
Q2 2023

Aug 01, 2023
SELL
$69.91 - $75.81 $92,490 - $100,296
-1,323 Reduced 6.1%
20,355 $1.46 Million
Q1 2023

May 05, 2023
BUY
$63.15 - $71.6 $526,797 - $597,287
8,342 Added 62.55%
21,678 $1.5 Million
Q4 2022

Jan 24, 2023
SELL
$54.21 - $70.44 $1,843 - $2,394
-34 Reduced 0.25%
13,336 $0
Q3 2022

Nov 10, 2022
SELL
$53.02 - $135.75 $39,605 - $101,405
-747 Reduced 5.29%
13,370 $733,000
Q2 2022

Aug 11, 2022
BUY
$59.26 - $71.14 $45,807 - $54,991
773 Added 5.79%
14,117 $933,000
Q1 2022

Apr 20, 2022
SELL
$55.72 - $67.12 $1,504 - $1,812
-27 Reduced 0.2%
13,344 $885,000
Q4 2021

Feb 02, 2022
SELL
$54.02 - $63.83 $228,720 - $270,256
-4,234 Reduced 24.05%
13,371 $779,000
Q3 2021

Oct 28, 2021
SELL
$55.56 - $60.79 $16,723 - $18,297
-301 Reduced 1.68%
17,605 $1.06 Million
Q2 2021

Aug 13, 2021
SELL
$48.42 - $60.18 $47,693 - $59,277
-985 Reduced 5.21%
17,906 $1.07 Million
Q1 2021

May 06, 2021
BUY
$47.16 - $54.44 $154,449 - $178,291
3,275 Added 20.97%
18,891 $939,000
Q4 2020

Feb 09, 2021
SELL
$48.52 - $58.02 $286,462 - $342,550
-5,904 Reduced 27.43%
15,616 $781,000
Q3 2020

Nov 03, 2020
BUY
$53.07 - $61.1 $596,135 - $686,336
11,233 Added 109.2%
21,520 $1.18 Million
Q2 2020

Jul 31, 2020
BUY
$43.1 - $55.31 $195,587 - $250,996
4,538 Added 78.94%
10,287 $544,000
Q1 2020

May 01, 2020
SELL
$37.79 - $51.33 $332,703 - $451,909
-8,804 Reduced 60.5%
5,749 $257,000
Q4 2019

Feb 03, 2020
BUY
$42.46 - $50.46 $3,948 - $4,692
93 Added 0.64%
14,553 $726,000
Q3 2019

Nov 01, 2019
SELL
$40.12 - $45.47 $26,960 - $30,555
-672 Reduced 4.44%
14,460 $645,000
Q2 2019

Aug 01, 2019
SELL
$37.28 - $41.68 $8,015 - $8,961
-215 Reduced 1.4%
15,132 $625,000
Q1 2019

May 01, 2019
SELL
$35.49 - $43.02 $13,024 - $15,788
-367 Reduced 2.34%
15,347 $621,000
Q4 2018

Jan 31, 2019
BUY
$36.86 - $41.49 $268,893 - $302,669
7,295 Added 86.65%
15,714 $597,000
Q3 2018

Nov 07, 2018
BUY
$34.76 - $39.72 $4,692 - $5,362
135 Added 1.63%
8,419 $333,000
Q2 2018

Aug 02, 2018
SELL
$34.55 - $37.05 $23,321 - $25,008
-675 Reduced 7.53%
8,284 $291,000
Q1 2018

May 11, 2018
BUY
$32.97 - $36.63 $21,562 - $23,956
654 Added 7.87%
8,959 $313,000
Q4 2017

Feb 07, 2018
SELL
$32.09 - $34.78 $17,296 - $18,746
-539 Reduced 6.09%
8,305 $288,000
Q3 2017

Nov 06, 2017
BUY
$28.96 - $34.0 $256,122 - $300,696
8,844
8,844 $300,000

Others Institutions Holding AZN

# of Institutions
1,510
Shares Held
501M
Call Options Held
5.59M
Put Options Held
3.18M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email